BE799372A - Nouveaux composes analogues a des prostaglandines, leur procede de preparation et medicament les contenant - Google Patents

Nouveaux composes analogues a des prostaglandines, leur procede de preparation et medicament les contenant

Info

Publication number
BE799372A
BE799372A BE130979A BE130979A BE799372A BE 799372 A BE799372 A BE 799372A BE 130979 A BE130979 A BE 130979A BE 130979 A BE130979 A BE 130979A BE 799372 A BE799372 A BE 799372A
Authority
BE
Belgium
Prior art keywords
prostaglandins
preparation process
product containing
new compounds
medicinal product
Prior art date
Application number
BE130979A
Other languages
English (en)
French (fr)
Inventor
N A Nelson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26941978&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE799372(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BE799372A publication Critical patent/BE799372A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE130979A 1972-05-10 1973-05-10 Nouveaux composes analogues a des prostaglandines, leur procede de preparation et medicament les contenant BE799372A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/252,030 US4304907A (en) 1972-05-10 1972-05-10 Bicyclo lactone intermediates for prostaglandin analogs
US05/426,058 US4303796A (en) 1972-05-10 1973-12-19 16-Phenoxy prostaglandin F2α analogs

Publications (1)

Publication Number Publication Date
BE799372A true BE799372A (fr) 1973-11-12

Family

ID=26941978

Family Applications (1)

Application Number Title Priority Date Filing Date
BE130979A BE799372A (fr) 1972-05-10 1973-05-10 Nouveaux composes analogues a des prostaglandines, leur procede de preparation et medicament les contenant

Country Status (8)

Country Link
US (8) US4304907A (US06815460-20041109-C00097.png)
AU (1) AU470415B2 (US06815460-20041109-C00097.png)
BE (1) BE799372A (US06815460-20041109-C00097.png)
CH (2) CH585712A5 (US06815460-20041109-C00097.png)
DE (1) DE2322673A1 (US06815460-20041109-C00097.png)
FR (1) FR2184007B1 (US06815460-20041109-C00097.png)
GB (3) GB1409841A (US06815460-20041109-C00097.png)
NL (1) NL7306462A (US06815460-20041109-C00097.png)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864387A (en) * 1973-05-21 1975-02-04 Upjohn Co 5-Oxa phenyl-and phenoxy-substituted prostaglandin F{HD 1{301 {0 {B analogs
GB1502610A (en) * 1974-12-12 1978-03-01 Ici Ltd Process for the preparation of prostaglandin intermediate
GB1538871A (en) * 1975-01-24 1979-01-24 Lepetit Spa Prostaglandins
US4032561A (en) * 1975-05-27 1977-06-28 The Upjohn Company 17-Phenyl-18,19,20-trinor-cis-4,5-didehydro-PGF1.sub.α compounds
DE2655004C3 (de) * 1976-12-02 1980-06-19 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von bicyclischen Laktonen
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain
DE3268099D1 (en) * 1982-06-15 1986-02-06 Ibm Method and apparatus for controlling access to a communication network
US4912235A (en) * 1983-12-22 1990-03-27 Syntex (U.S.A.) Inc. Processes and intermediates for making 16-phenoxy- and 16-substituted phenoxy-prostatrienoic acid derivatives and their stereoisomers
US4804787A (en) * 1983-12-22 1989-02-14 Syntex (U.S.A.) Inc. Processes and intermediates for making 16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives
US4600785A (en) * 1983-12-22 1986-07-15 Syntex (U.S.A.) Inc. Processes and intermediates for making 16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives
US4929740A (en) * 1984-10-09 1990-05-29 Syntex (U.S.A.) Inc. Process for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives
US4778904A (en) * 1985-09-13 1988-10-18 Syntex (U.S.A.) Inc. Intermediates for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives
US4755531A (en) * 1986-08-11 1988-07-05 Syntex (U.S.A.) Inc. Thiol esters of 4,5-allenyl prostaglandins and use thereof as antigastric secretion agents
CS264861B1 (en) * 1986-12-12 1989-09-12 Kral Josef Agent for cow natality increase
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ES2213504T1 (es) * 1988-09-06 2004-09-01 Pfizer Health Ab Derivados de prostaglandina para el tratamiento del glaucoma o hipertension ocular.
JP3097145B2 (ja) * 1991-02-27 2000-10-10 日産化学工業株式会社 コーリーラクトンジオールの光学分割方法
EP0638605B1 (en) * 1993-08-10 1998-12-09 Shin-Etsu Chemical Co., Ltd. Process for preparing a polyester-modified silicone resin and a curable composition comprising the polyester-modified silicone resin
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US9241918B2 (en) 2005-03-16 2016-01-26 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
WO2010108012A1 (en) * 2009-03-18 2010-09-23 Duke University Compositions and methods for promoting nasal patency and treating neurogenic bladder using prostaglandins
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
US20110206647A1 (en) * 2010-02-25 2011-08-25 Abt Holding Company Modulation of Angiogenesis
SG10201501353YA (en) * 2010-02-25 2015-04-29 Abt Holding Co Modulation of angiogenesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505386A (en) * 1965-12-29 1970-04-07 Upjohn Co Compounds related to prostaglandins
US3711528A (en) * 1970-04-06 1973-01-16 Upjohn Co Racemic dihydro-pge{11 {11 and related compounds
US3711515A (en) * 1970-11-27 1973-01-16 Upjohn Co Tricyclic lactone alkene or alkenyne
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives
US4024179A (en) * 1972-11-08 1977-05-17 Pfizer Inc. Substituted ω-pentanorprostaglandins

Also Published As

Publication number Publication date
DE2322673A1 (de) 1973-11-22
US4096335A (en) 1978-06-20
FR2184007B1 (US06815460-20041109-C00097.png) 1979-01-12
US4096178A (en) 1978-06-20
GB1409843A (en) 1975-10-15
AU470415B2 (en) 1976-03-18
AU5500673A (en) 1974-10-31
CH585712A5 (US06815460-20041109-C00097.png) 1977-03-15
US4087616A (en) 1978-05-02
US4116988A (en) 1978-09-26
US4096179A (en) 1978-06-20
NL7306462A (US06815460-20041109-C00097.png) 1973-11-13
CH585711A5 (US06815460-20041109-C00097.png) 1977-03-15
GB1409841A (en) 1975-10-15
US4303796A (en) 1981-12-01
GB1409842A (en) 1975-10-15
US4116989A (en) 1978-09-26
FR2184007A1 (US06815460-20041109-C00097.png) 1973-12-21
US4304907A (en) 1981-12-08

Similar Documents

Publication Publication Date Title
BE799372A (fr) Nouveaux composes analogues a des prostaglandines, leur procede de preparation et medicament les contenant
FR2353290A1 (fr) Nouveaux analogues de prostaglandines, leur procede de preparation et medicament les contenant
BE836924A (fr) Nouveaux azolyl - (1) - methanes et leurs sels, leur procede de preparation et medicament les contenant
FR2293928A1 (fr) Nouveaux derives d'acide 3-amino-indazolecarboxylique, leur procede de preparation et medicament les contenant
BE829052A (fr) Nouvelles phenylguanidines substituees, leur procede de preparation et medicament les contenant
BE874135A (fr) Nouveaux analogues de prostacycline, leur procede de production et medicament les contenant
BE855713Q (fr) Nouveaux derives de 4-aminoquinoleine, leur procede de preparation et medicament les contenant
FR2287916A1 (fr) Nouveaux derives dipeptidiques, leur procede de preparation et medicament les contenant
FR2315268A1 (fr) Nouvelles lactones de prostaglandines, leur procede de preparation et medicament les contenant
BE829417A (fr) Nouveaux pyrimidinols, leur procede de preparation et medicament les contenant
FR2303538A1 (fr) Nouveaux ethers cycliques, leur procede de preparation et medicament les contenant
FR2292471A1 (fr) Nouveaux antibiotiques du type b-lactame, leur procede de preparation et medicament les contenant
FR2289184A1 (fr) Medicament contenant un derive de carboxy-thioxanthone
BE804092A (fr) Nouveaux 1-ethyl-imidazoles, leur procede de preparation et medicaments les contenant
FR2297845A1 (fr) Nouveaux analogues de prostaglandines, leur procede de preparation et medicament les contenant
FR2292474A1 (fr) Nouveaux diaryloxy-imidazolyl-o,n-acetals, leur procede de preparation et medicament les contenant
FR2274288A1 (fr) Nouveaux composes arylsulfonylcarbamoyl-1,3-dicarbonyliques, leur procede de preparation et medicament les contenant
FR2292483A1 (fr) Nouveau derive de la butirosine a, son procede de preparation et medicament le contenant
BE836022A (fr) Nouveaux antibiotiques du type beta-lactame, leur procede de preparation et medicament les contenant
BE804161A (fr) Procede de preparation de 3,4-dihydropyridones et medicament contenant ces composes
FR2312236A1 (fr) Nouveaux composes de la classe des prostaglandines, leur procede de preparation et medicament les contenant
FR2273530A2 (fr) Nouveaux acides et sels cyanophenylene-dioxamiques, leur procede de preparation et medicament les contenant
BE802496A (fr) Nouveaux 2-amino-4h-pyrannes, leur procede de preparation et medicament les contenant
FR2301239A1 (fr) Nouveaux analogues de prostaglandines, leur procede de preparation et medicament les contenant
BE827119A (fr) Nouveaux 1-arylucaciles, leur procede de preparation et medicament les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE UPJOHN CY

Effective date: 19850510